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ABSTRACT 
ORAI and STIM are store-operated channel molecules that play essential roles in human 
physiology through a coupling mechanism of internal Ca2+ store to Ca2+ influx. However, the 
roles of ORAI and STIM in vascular endothelial cells under diabetic conditions remain 
unknown. Here we investigated expression and signalling pathways of ORAI and STIM 
regulated by high glucose or hyperglycaemia using in vitro cell models, in vivo diabetic mice 
and tissues from patients. We found that ORAI1-3 and STIM1-2 were ubiquitously expressed 
in human vasculatures. Their expression was upregulated by chronic treatment with high 
glucose (HG, 25 mM D-glucose), which was accompanied by enhanced store-operated Ca2+ 
influx in vascular endothelial cells. The increased expression was also observed in the aortae 
from genetically modified Akita diabetic mice (C57BL/6-Ins2Akita/J) and streptozocin-
induced diabetic mice, and aortae from diabetic patients. HG-induced upregulation of ORAI 
and STIM genes was prevented by the calcineurin inhibitor cyclosporin A and NFATc3 
siRNA. Additionally, in vivo treatment with the NFAT inhibitor A-285222 prevented the 
gene upregulation in Akita mice. However, HG had no direct effects on ORAI1-3 currents 
and the channel activation process through cytosolic STIM1 movement in the cells co-
expressing STIM1-EYFP/ORAIs. We concluded that upregulation of STIM/ORAI through 
Ca2+-calcineurin-NFAT pathway is a novel mechanism causing abnormal Ca2+ homeostasis 
and endothelial dysfunction under hyperglycaemia.  
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Introduction 
Cardiovascular mortality has decreased over the last 40 years in Western countries; however, 
patients with diabetes still have high mortality and show a two- to four-fold increased risk of 
cardiovascular events over those without diabetes [1]. This increased risk is generally 
attributed to the adverse effects of hyperglycaemia and oxidative stress, the two main factors 
that cause vascular endothelial cell damage and consequently diabetic vascular complications 
[2].  
Ca2+ signalling is critical in regulating endothelial function. Many inflammatory mediators, 
such as thrombin, histamine and cytokines, increase intracellular Ca2+ concentration ([Ca2+]i) 
through activation of G protein-coupled receptors or receptor tyrosine kinases [3, 4]. 
Signalling through these receptors leads to the generation of inositol 1, 4, 5-trisphosphate 
(IP3), IP3 receptor activation, depletion of Ca
2+ from intracellular stores, and the opening of 
Ca2+-permeable channels in the plasma membrane, i.e., store-operated channels (SOCs) or 
Ca2+ release-activated channels (CRACs) [4]. ORAI and transient receptor potential (TRP) 
channel proteins have been proposed as the molecular fingerprints for SOCs. ORAIs mediate 
the highly Ca2+-selective and inward rectifying Ca2+ release-activated Ca2+ current (ICRAC) [5, 
6], while TRPCs mediate the non-selective Ca2+-permeable cationic current with outward 
rectification [7, 8]. These channels are associated with the Ca2+ sensor protein STIM1 
(stromal interaction molecule 1) in the endoplasmic reticulum (ER), which senses the 
depleted Ca2+ store and couples to the SOCs in the plasma membrane through 
subplasmalemmal translocation and clustering [9-13].  
ORAI and TRPC channels play important roles in the regulation of endothelial function 
including permeability, proliferation, migration, secretion, apoptosis and angiogenesis [14-
16]. Changes in the expression of TRPC channels have been reported in the context of 
diabetes. For example, TRPC1 and TRPC6 were shown to be upregulated in the smooth 
muscle of tail artery from Goto-Kakizaki type 2 diabetic rats [17], but downregulated in 
diabetic human saphenous vein [18]. In human umbilical vein endothelial cells (HUVECs), 
increased SOC activity was suggested to mediate high glucose (HG)-induced apoptosis [19]. 
Store-operated Ca2+-entry was impaired due to decreased STIM1 expression in the coronary 
artery endothelial cells isolated from streptozotocin-induced diabetic mice [20]; however, an 
opposite effect was reported in human glomerular mesangial cells [21]. The effect of HG on 
ORAI channels is still unknown. Here, we investigated the expression of ORAIs and STIMs 
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and their regulatory mechanisms under HG condition and hyperglycaemic state using in vitro 
cell models and tissue samples from diabetic mice and patients. 
 
Materials and methods 
Animals and human blood vessel samples  
Akita type 1 diabetic mice (C57BL/6-Ins2Akita/J) were obtained from the Jackson laboratories 
and bred at Lund University. Heterozygous Akita and control wild-type adult mice (mix 
genders at 12 ± 1 weeks old) were treated with daily intraperitoneal (i.p.) injections of NFAT 
blocker A-285222 (Abbott Laboratories, Abbott Park, IL) at a dose of 0.29 mg per kg body 
weight or vehicle (saline) for four weeks. At the end of the study, mice were anaesthetized by 
i.p. injection of ketamine hydrochloride and xylazine (2.5 mg and 7.5 mg/100 g body weight, 
respectively) and euthanized by exsanguination through cardiac puncture, after which the 
abdominal aortae were dissected out, cleaned and frozen in liquid nitrogen for future mRNA 
analysis. Also, adult C57BL/6 mice (12-15 weeks old) were used as streptozocin (STZ)-
induced type 1 diabetic model by i.p. injections of STZ (Sigma-Aldrich, Stockholm, Sweden; 
60 mg/kg body weight, pH 4.5) once a day for 5 days, as previously described, and the 
control mice received vehicle (citrate buffer) instead [22]. The animal study conforms to the 
Guide for the Care and Use of Laboratory Animals published by the Directive 2010/63/EU of 
the European Parliament. The use of animal for research was approved by the Malmö/Lund 
Animal Care and Use Committee. 
Human aorta, saphenous vein, left internal mammary artery (LIMA) and renal artery samples 
were obtained from patients undergoing cardiac surgery or nephrectomy in East Yorkshire 
NHS Trust Hospitals. The project was approved by the local ethics committee and patients 
gave informed consent in accordance with the Declaration of Helsinki. Samples were 
collected in cold Hank’s balanced salt solution (Invitrogen, UK) and transported into the 
laboratory immediately for experiments.  
Cell culture 
Primary human aortic endothelial cells (HAECs) were purchased from PromoCell 
(Heidelberg, Germany). Endothelial cells EA.hy926, a permanent cell line derived from 
HUVECs, were purchased from American Type Culture Collection (ATCC) (Middlesex, 
UK). Endothelial cells were cultured in endothelial cell medium (PromoCell, Germany) 
supplemented with 2% fetal calf serum (FCS), 0.1 ng/ml recombinant human epidermal 
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growth factor, and 1 ng/ml basic fibroblast growth factor. Cells were maintained at 37°C 
under 95% air and 5% CO2. HEK293 T-REx cells were grown in DMEM-F12 medium 
(Invitrogen, UK) containing 10% FCS, 100 units/ml penicillin and 100 µg/ml streptomycin. 
Cells were seeded on coverslips prior to experiments. Smooth muscle cells isolated from 
human saphenous vein and rat aorta were cultured [7] and used at passages 2-3.  
Cloning and transfection 
The full length of human ORAI1, ORAI2 and ORAI3 cDNAs were amplified from HAECs 
by RT-PCR and cloned into a tetracycline-regulatory vector pcDNA4/TO as we reported 
[13]. The sequences are 100% identical to the GenBank sequences with accession numbers 
NM_032790, NM_001126340 and NM_152288. The plasmid ORAI1 and ORAI2 cDNAs 
tagged with mCherry (monomeric cherry red fluorescence) and ORAI3 tagged with mCFP 
(monomeric cyan fluorescent protein) were transfected into HEK-293 T-REx cells using 
Lipofectamine 2000 (Invitrogen, Paisley, UK). For electrophysiological experiments, the 
tetracycline-inducible ORAI1-3 cells were cotransfected with STIM1 tagged with enhanced 
yellow fluorescent protein (STIM1-EYFP). Gene expression was induced by 1 μg/ml 
tetracycline for 24 h before recordings. For the study on NFAT signalling, the endothelial 
cells EA.hy926 were transfected with NFATc3 siRNA (Santa Cruz Biotech, Texas, USA) and 
reporter gene EYFP using Lipofectamine 2000 with similar procedures we described 
previously [23].  
Real-time RT-PCR 
Total RNA was extracted from cultured cells or tissues using NucleoSpin RNA II kit 
(Macherey-Nagel, Düren, Germany), and reverse transcribed with the moloney murine 
leukaemia virus (M-MLV) reverse transcriptase using random primers (Promega, UK). For 
mouse abdominal aorta samples, total RNA was isolated using TriReagent (Sigma-Aldrich, 
Poole, UK). Quantitative RT-PCR was performed using StepOneTM real-time PCR System 
(Applied Biosystems, UK). The primers were designed across introns and the sequences are 
given in Supplementary Table 1. Each reaction contained 5 μl SYBR® Green PCR Master 
Mix (Applied Biosystems, UK), 0.5 μl of 10 μM forward primer, 1 μl of 10 μM reverse 
primer, 1 μl cDNA and 2.5 μl H2O. The PCR cycle consisted of an initial denaturation step of 
94°C for 5 minutes followed by 55 repeated cycles of 94°C for 30 seconds, 54°C for 45 
seconds, and 72°C for 45 seconds, with a final cycle of extension at 72°C for 10 minutes. The 
melting curve analysis was performed for quality control. β-actin was used as house-keeping 
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gene control for quantification. PCR products were also confirmed by 2% agarose gel 
electrophoresis or direct sequencing.  
Western blotting 
Cells were lysed in RIPA buffer (Sigma-Aldrich, Poole, UK) and proteins were separated on 
10% SDS-PAGE gel before transferring onto nitrocellulose membrane [24]. The blot was 
incubated with rabbit polyclonal anti-human ORAI1, ORAI2, STIM1, STIM2 (Alomone 
Labs, Jerusalem, Israel) and ORAI3 (ProSci Incorporated, Poway, CA, USA) antibodies 
overnight at 4 °C, washed with phosphate buffered saline (PBS) and then incubated with goat 
anti-rabbit IgG-HRP (1:2000 dilution) (Sigma). The rabbit anti-β-actin (1:400 dilution) 
(Santa Cruz Biotech, USA) was used as an internal standard for protein quantification. 
Visualization was carried out using ECLplus detection reagents (GE Healthcare, UK) with X-
ray films or photographed by a gel documentation system (UVP, Cambridge, UK). The band 
density was analysed using ImageJ software (NIH, USA). 
Immunohistochemistry and immunofluorescence 
Paraffin-embedded human LIMA tissue sections with a thickness of 5 μm were stained with 
rabbit anti-ORAI1, anti-ORAI2 and anti-ORAI3 antibodies using VECTASTAIN ABC kit 
(Vector Labs, Peterborough, UK). All sections underwent deparaffinisation, endogenous 
peroxidase blocking, and the blocking in non-specific serum to ensure the staining was 
specific. ORAI1, ORAI2 and ORAI3 primary antibodies at 1:250 dilutions were used and the 
tissue sections were incubated at 4C overnight followed by biotinylated anti-mouse/rabbit 
immunoglobulins at 1:1000 for 20 min. Incubations with antigen pre-absorbed antibodies or 
without primary antibody were used as negative controls.  
Frozen tissue sections of kidney containing small arteries were fixed with 4% 
paraformaldehyde and permeabilised by incubation in -20°C methanol for 1 minute and 0.1% 
Triton X-100 in PBS for 2 hours at room temperature. Sections were incubated in 1% bovine 
serum albumin (BSA) to block non-specific binding and then incubated in the appropriate 
ORAI primary antibodies at 1:200-500 dilutions in PBS with 1% BSA at 4°C overnight. 
Tissue sections were washed three times with PBS then incubated in the sheep anti-rabbit IgG 
conjugated with FITC (Sigma) at a dilution of 1:160 for 2 hours at room temperature. 
Sections were double stained with Cy3 conjugated monoclonal anti-α-smooth muscle actin 
(α-SMA) at a dilution of 1:200 (Sigma). After three washes with PBS, coverslips were 
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mounted using Vectashield mounting medium (Vector Laboratories). The staining was 
photographed using a fluorescent microscope with acquisition software. 
Electrophysiology, Ca2+ dye and live cell fluorescent imaging 
Whole‐cell patch‐clamp recordings were performed on the HEK293 T‐REx cells 
overexpressing mCherry-ORAIs and STIM1-EYFP as the procedures described [25]. The 
standard bath solution contained (mM): 130 NaCl, 5 KCl, 8 D-glucose, 10 HEPES, 1.2 
MgCl2 and 1.5 CaCl2. The pH was adjusted to 7.4 using NaOH. The pipette solution 
contained (mM): 145 Cs-methanesulfonate, 10 BAPTA, 10 HEPES, 8 MgCl2, and the pH 
was titrated to 7.2 with CsOH. The recording chamber had a volume of 150 μl and was 
perfused at a rate of about 2 ml/min. The glass pipette with 3-5 M resistance was used and a 
1-s voltage ramp from -100 mV to +100 mV was applied. The electrical signal was acquired 
by pClamp10. Experiments were performed at room temperature (22-26°C).  
For Ca2+ imaging experiments, the EA.hy926 cells on coverslips were incubated with 1 μM 
Fura-PE3/AM for 30 min at 37°C in standard bath solution and washed with  Ca2+ free 
standard bath solution (Ca2+ was replaced by 0.4 mmol/L EGTA) for 2 min before recording. 
The ratio (F340/F380) of Ca
2+ dye fluorescence was measured by a Nikon Ti-E system with 
NIS-Element Ca2+ imaging software (Nikon, Tokyo, Japan). For live cell fluorescent 
imaging, the stable cells transfected with STIM1-EYFP were used and the movement of 
STIM1-EYFP fluorescence were monitored using the Nikon Ti-E imaging system [13]. 
Statistics 
All values are expressed as mean ± SEM. Unpaired student's t test and ANOVA with 
Dunnett's post-hoc analysis were used for comparison of 2 groups and more than 2 groups, 
respectively. The significance is indicated if P<0.05. 
 
Results 
STIM and ORAI expression and regulation by HG  
The mRNAs of ORAI1-3 and STIM1-2 were detected by RT-PCR in fresh human blood 
vessels including aorta, LIMA, saphenous vein, as well as in human endothelial cells (ECs) 
and smooth muscle cells (SMCs) (Fig. 1A). ORAI and STIM proteins were also detected by 
Western blotting in HAECs (Fig. 1B), EA.hy926 and human LIMA (Supplementary Fig. 1). 
Positive immunostaining was seen both in the endothelium and smooth muscle layer in 
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human LIMA (Fig. 1C) and small renal arteries (Fig. 1D), suggesting that ORAI and STIM 
are ubiquitously expressed in vascular endothelial and smooth muscle cells in various 
vascular beds. 
Using real-time PCR, we found that the mRNA levels of ORAI1, 2, 3 and STIM1, 2 were 
significantly upregulated in the endothelial cells incubated with HG (25 mM) for 72 h (Fig. 
1E). Protein levels of ORAI and STIM isoforms in the HG-treated cells were also increased 
(Fig. 1F). Similar upregulation by HG was observed in primary cultured rat aortic smooth 
muscle cells (Supplementary Fig. 2A). 
The findings on in vitro cell models were further confirmed using arteries form type 1 
diabetic Akita mice. These mice have a mutation in the insulin 2 gene (Ins2Akita) and are 
characterized by hyperglycaemia without significant weight loss (see Supplementary Table 
2). Expression of ORAI1-3 and STIM1-2 mRNAs was significantly increased in the 
abdominal aorta of Akita mice when compared to samples from wild-type controls (Fig. 2A). 
Same results were observed in abdominal aortae from STZ-diabetic mice when compared to 
arteries from control non-diabetic mice (Supplementary Fig. 3). We also examined the 
expression in diabetic human aorta samples from type 2 diabetic patients (male; 57 ± 2.8 
years of age) undergoing cardiac bypass surgery. Samples from age- and body mass index 
(BMI; 30 ± 1.6 kg/m2 vs 30 ± 2.0 kg/m2, P > 0.05) -matched male patients without diabetes 
were used as control. Expression of ORAI1, ORAI2, STIM1 and STIM2 mRNAs was 
significantly higher in the aortae obtained from diabetic patients (Fig. 2B). These data 
suggest that the ORAIs and STIMs are upregulated in diabetes. 
Upregulation of ORAI and STIM is mediated by Ca2+-calcineurin-NFATc signalling 
The Ca2+-calcineurin-NFAT signalling pathway was examined using in vitro cell models and 
in vivo Akita mouse model. HG-induced upregulation of ORAIs and STIMs was prevented 
by incubation with the calcineurin inhibitor cyclosporin A (CsA, 200 nM) for 48 h in vascular 
endothelial cells (Fig. 3A) and in smooth muscle cells (Supplementary Fig. 2B). Application 
of CsA alone also reduced the expression of ORAI1-3 and STIM1-2 in endothelial cells, 
suggesting that the basal activity of calcineurin signalling could be essential for maintaining 
constitutive ORAI and STIM gene expression (Fig. 3A). NFATc3 has previously been shown 
to be activated by hyperglycaemia in vascular smooth muscle through a mechanism involving 
intracellular Ca2+ increase via P2Y receptors and subsequent activation of calcineurin, 
combined with the inhibition of GSK-3β and JNK that can reduce NFATc3 nuclear export 
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[22, 26]. Therefore the role of this particular isoform in HG-induced gene expression was 
also examined in the endothelial cells using RNA interference. The endogenous NFATc3 
expression was nearly abolished after transfection with specific NFATc3 siRNA (Fig. 3B). 
HG significantly increased the expression of NFATc3 (Fig. 3C). Knockdown of NFATc3 by 
siRNA prevented the HG-induced upregulation of ORAI1-3 and STIM1-2 (Fig. 3D). To 
further confirm the regulation through calcineurin-NFATc pathway in vivo, Akita and control 
non-diabetic mice were treated with daily i.p. injections of the NFAT blocker A-285222 (0.29 
mg/kg body weight) or vehicle (saline) for 4 weeks and then abdominal aortae were harvested 
for real-time PCR. The enhanced expression of ORAI and STIM in Akita mice was 
significantly decreased by treatment with A-285222 (Fig. 3E). These data suggest that the 
upregulation of ORAI and STIM gene expression by HG is mediated by the Ca2+-calcineurin-
NFATc signalling pathway. 
HG enhanced Ca2+ release and influx in vascular endothelial cells 
To examine SOC activity under high glucose conditions, Ca2+ influx was monitored using 
Fura-PE3/AM in vascular endothelial cells EA.hy926. Acute application of HG (25 mM) did 
not change Ca2+ influx in the cells pretreated with or without thapsigargin (TG, 1 μM) (Fig. 
4A-C ). In contrast, incubation of the cells with 25 mM glucose for 72 h resulted in enhanced 
store-operated Ca2+ influx without affecting basal Ca2+ level (Fig. 4D-E). The effects of HG 
on non-store-depleted Ca2+ influx, Ca2+ release and store-depleted Ca2+ influx after active ER 
Ca2+ store depletion were also observed using trypsin, an activator of G protein-coupled 
receptor. The non-store-depleted Ca2+ influx was greater in the cells incubated with HG. The 
Ca2+ release signal and Ca2+ influx induced by trypsin (0.1 nM) were also significantly higher 
in the HG-treated group than those in the control group (Fig. 4F-G). These data suggest that 
HG has no acute effect on Ca2+ influx, but it enhances store-operated Ca2+ influx, non-store-
operated Ca2+ influx and Ca2+ release in the cells exposed to HG chronically.  
Direct effects of HG on ORAI channel activity and STIM1 movement 
To determine whether HG affects ORAI channel opening, whole-cell patch clamp was 
performed in the inducible HEK293 T-REx cells coexpressing STIM1-EYFP and mCherry-
tagged ORAI1 or ORAI2, or mCFP-tagged ORAI3. Perfusion with 25 mM glucose did not 
change the TG-induced ORAI1 and ORAI2 currents and the 2-APB-induced ORAI3 current; 
however, DES significantly inhibited the currents of all three ORAI isoforms (Fig. 5A-D).  
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STIM1 subplasmalemmal translocation and clustering are essential steps for triggering ORAI 
channel opening, which could serve as targets for SOC regulators [10, 13], we therefore 
examined if HG affects STIM1 translocation and clustering. In the HEK293 T-REx cells 
overexpressing STIM1-EYFP, the STIM1 subplasmalemmal translocation and puncta 
formation were evoked by TG (Fig. 5E), but acute perfusion with HG or chronic treatment by 
incubation with HG for 72 h did not cause STIM1 clustering or affect the TG-induced STIM1 
movement (Fig. 5E-G). These data suggest that HG has no direct effects on ORAI channel 
activity and intracellular STIM1 movement. 
 
Discussion 
In this study, we have shown that store-operated Ca2+ entry in vascular endothelial cells and 
smooth muscle cells is enhanced by chronic treatment with HG. The enhancement is 
mediated by upregulation of ORAI1-3 and STIM1-2 expression, rather than by direct channel 
activation of ORAI1-3 or movement of STIM1 during store-operated channel activation. 
STIMs and ORAIs upregulation was also demonstrated in vivo using samples from type 2 
diabetic patients and from type 1 diabetic animal models. Inhibition of calcineurin/NFAT 
signalling pathway, either via decreased activation by calcineurin or A-285222 or via 
decreased expression of NFATc3 via siRNA, prevents the HG-induced STIM and ORAI gene 
upregulation. These findings suggest that the upregulation of store-operated channel 
molecules is responsible for the enhanced store-operated channel function seen in 
hyperglycaemia and diabetic conditions. 
Previous studies have shown that HG affects intracellular Ca2+ level or Ca2+ homeostasis [27-
29]. The different responses between acute application and chronic treatment has been 
demonstrated, i.e., acute application of HG had less effect on Ca2+ influx, but chronic 
treatment by incubation with HG for 2-4 days significantly increased the Ca2+ influx in 
HUVECs [19], porcine aortic endothelial cells [30] and in EA.hy926 cells as shown in this 
study and others [31]; however, an opposite effect was reported in mouse coronary 
endothelial cells [20]. In vascular endothelial cells, chronic treatment with HG not only 
increases store-operated Ca2+ entry, but also increases the Ca2+ release and OAG-induced 
Ca2+ influx [32], which suggests other Ca2+-permeable channels may also be involved in the 
regulation of Ca2+ homeostasis in hyperglycaemia, such as the regulation of TRPC1, TRPC3-
6, and TRPM6-7 in human monocytes, platelets and endothelial cells under diabetic 
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conditions or hyperglycaemia [17, 18, 32-34]. In this study, we have not explored other 
channels, but focused on the store-operated components related to STIMs and ORAIs. The 
mechanism for HG-induced upregulation of store-operated channel genes is unclear, here we 
suggest that the Ca2+/calcineurin signalling pathway is important for ORAI and STIM gene 
expression, because inhibition of calcineurin or NFAT with CsA or A-285222, respectively, 
or silencing of NFATc3 expression using siRNA prevents the HG-induced effect. In addition, 
NFATc3 was upregulated by HG as shown in this study, and increased activity and nuclear 
accumulation of NFATc3 were also observed in the diabetic mice with hyperglycaemia in 
vivo [22]. These data further demonstrate the role of Ca2+/calcineurin/NFATc3 signalling 
pathway in the HG-induced gene regulation. Although cytosolic Ca2+ is essential for 
activating or maintaining the activity of Ca2+/calcineurin/NFATc3 signalling, other 
mechanisms may also be involved in the gene regulation under hyperglycemic or diabetic 
conditions, such as mitochondrial stress signalling, intracellular Ca2+ dynamics, and some 
kinase activities. For example, GSK-3β and JNK can decrease NFATc3 nuclear export [26]. 
On the other hand, overproduction of reactive oxygen species (ROS) under high glucose or 
diabetic conditions could be another potential pathway for gene regulation, since H2O2 can 
directly activate the ICRAC current and other Ca
2+-permeable channels [23, 35, 36], increase 
cytosolic Ca2+ concentration and subsequently activate the downstream calcineurin/NFAT 
signaling. In addition, an oxidative stress mechanism has also been suggested for TRPC3 and 
TRPC6, since the membrane-permeable radical scavenger, tempol, prevented the effect of 
HG [34]. Therefore, oxidative stress could directly alter the Ca2+ homeostasis through non-
store-operated pathways, such as TRPM2, and thus alter the downstream Ca2+/calcineurin 
signaling and gene transcription [37]. Although the evidence for the upregulation of ORAIs 
and STIMs in vascular endothelia cells and smooth muscle cells are evident, the response to 
HG for other Ca2+ channels in different cell types is still unclear, such as downregulation of 
TRPC6 and decreased receptor-operated Ca2+ influx found in diabetic mesangial cells [38, 
39]. Recently, ORAI1/3 channels, but not ORAI2, could mediate arachidonic acid and 
leukotriene C4 regulated non-store-operated Ca2+ influx and current through interaction with 
plasma membrane STIM1[40], therefore, upregulation of ORAI1-3 and STIM1-2 could also 
be responsible for the enhanced non-store operated Ca2+ entry, particularly under the 
conditions of increased vascular or endothelial inflammatory response seen in diabetes and 
hyperglycemia.  
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In conclusion, HG increases store-operated calcium entry by upregulation of ORAI and 
STIM in vitro and in vivo via the Ca2+/calcineurin/NFAT pathway. The increased store-
operated channel activity or related gene expression is a potential critical step in the 
pathophysiology of diabetic vascular complications. Further elucidation of this Ca2+ 
signalling pathway may provide  new potential therapeutic opportunities for the treatment of 
these vascular complications in patients with  diabetes.  
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Figure 1. ORAI and STIM expression and regulation by HG. A, The mRNAs of ORAI1 
(238bp), ORAI2 (210bp), ORAI3 (176bp), STIM1 (183bp) and STIM2 (202bp) were 
detected by RT-PCR using the primers across introns (Supplementary Table 1) in human left 
internal mammalian artery (LIMA), aorta, human saphenous vein (HSV), human aortic 
endothelial cells (HAECs), endothelial cell line EA.hy926, and smooth muscle cells (SMC) 
isolated from HSV. The β-actin (211bp) was used as positive control and the reaction without 
reverse transcriptase (no RT) was used as a negative control. B, ORAI and STIM proteins 
were detected in HAECs by western blotting with the protein band size for ORAI1 (31 kDa), 
ORAI2 (29 kDa), ORAI3 (31 kDa), STIM1 (77 kDa) and STIM2 (94 kDa). C, 
Immunostaining of paraffin-embedded sections of LIMA using Vectorshield ABC kit. 
Positive staining is shown as brown colour. Scale bar is 100 µm. D, Dual fluorescent staining 
of frozen sections of human renal arteries with anti-smooth muscle alpha actin (α-SMA, red) 
and anti-ORAI1-3 antibodies (green). Scale bar is 25 µm. E, The mRNA of ORAIs and 
STIMs detected by real-time PCR in vascular endothelial cells EA.hy926 after incubation 
with high glucose (HG, 25 mM) for 72 h. RT-PCR reactions were performed for each sample 
(n = 3 for each group with triplicate PCR reactions), and β-actin was used as control for 
relative quantification. F, ORAI and STIM proteins detected by Western blotting in 
EA.hy926 cells. Mean ± SEM data were obtained from 3 independent experiments. *P<0.05, 
**P<0.01, ***P<0.001. 
 
Figure 2. ORAI and STIM expression in Akita mice and diabetic patients A, ORAI and 
STIM expression in Akita type 1 diabetic mice (n = 6 mice). The wild-type mice were set as 
control group. B, The mRNA levels of ORAIs and STIMs detected by real-time PCR in the 
aorta samples from type 2 diabetic patients (n = 4 paired patients). Triplicate RT-PCR 
reactions were performed for each sample. 
 
Figure 3. Regulation of ORAI and STIM expression by Ca2+-calcineurin signalling. A, 
The mRNA level quantified by real-time PCR in EA.hy926 cells after treatment with high 
glucose (25 mM), mannitol (19.5 mM) plus 5.5 mM glucose as equal osmolarity control 
(control), cyclosporin A (CsA, 200 nM), and high glucose plus CsA for 48 h (n = 3) . B, 
Agarose gel showing NFATc3 PCR band in the non-transfected control EA.hy926 cells (lane 
1-3) and the NFATc3-siRNA transfected cells (lane 4-6). The mean ± SEM data was showed 
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below (n = 6). C, The NFATc3 mRNA detected by real-time PCR after siRNA transfection 
and incubation with HG (25 mM) or mannitol (19.5 mM) plus 5.5 mM glucose as equal 
osmolarity control group for 48 h (n = 6). D, Relative mRNA levels of STIMs and ORAIs in 
mannitol control (19.5 mM mannitol + 5.5 mM glucose), high glucose (HG, 25 mM), and HG 
in cells transfected with NFATc3 siRNA (HG + siNFATc3). N = 3 for each group with 
triplicate PCR reactions. All the three groups were transfected with pEGFP vector with green 
fluorescence as reporter gene to see the transfection efficiency. E, Real-time PCR detection 
of ORAI and STIM in the aortae after injection with A-285222 (n = 7 for Akita group and 8 
for wild-type) or vehicle (n = 6 for Akita group and 8 for wild-type). Triplicate reactions 
were set for each sample and β-actin was used for quantification. **P<0.01, ***P<0.001 (HG 
vs mannitol control). #: P<0.001 (for comparisons vs HG or hyperglycaemia). 
Figure 4. Ca2+ influx regulated by high glucose in human vascular endothelial cells. A, 
Vascular endothelial cells EA.hy926 were loaded with Fura-PE3/AM and pretreated with 1 
µM thapsigargin (+TG) for 30 min. The fluorescence at a ratio of F340/380 was monitored 
before and after perfusion with high glucose (25 mM) (n = 17 cells). B, Acute application of 
mannitol (25 mM) on Ca2+ influx in the store-depleted cells with TG (n = 16 cells). C, Acute 
application of high glucose (25 mM) on Ca2+ influx in the cells without TG pretreatment 
(non-TG, n = 15 cells). D, Store-operated Ca2+ influx in the endothelial cells after incubation 
with or without high glucose for 72 h. The ER Ca2+ store was depleted by preincubation with 
1 µM TG for 30 min. E, Mean ± SEM data showed the ratio measured in Ca2+ free and 1.5 
mM Ca2+ solutions in the groups with (n = 52) or without (n = 49) chronic (72 h) incubation 
with high glucose as shown in (D). F, After 72 h incubation with or without high glucose, the 
Ca2+ influx was measured after admission of Ca2+, trypsin, and readmission of Ca2+. G, Mean 
± SEM data for the Ca2+ influx, Ca2+ release and Ca2+ reentry in the high glucose-treated (n = 
57) and untreated (n = 53) cells. *P<0.05, **P<0. 01, ***P<0.001 
 
Figure 5. Effects of high glucose on ORAI channel activity and STIM1 movement. 
Whole-cell current was recorded in the inducible HEK293 T-REx cells co-overexpressing 
STIM1-EYFP and ORAI1-2 tagged with mCherry (red fluorescence), or ORAI3 tagged with 
mCFP (pseudo-red colour) and in the non-transfected cells. A, ORAI1. B, ORAI2. C, ORAI3. 
D, Non-transfected cell as control. The ORAI1 and ORAI2 channels were activated by 1 μM 
thapsigargin in the bath solution and ORAI3 channel was activated by 100 μM 2-APB in the 
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bath solution. Representative subtracted I/V curves and time-courses are presented. Bar charts 
present the averaged data showing the effect of high glucose (HG, 25 mM) and 
diethylstilbestrol (DES, 1 µM) on the channel activity (n = 12 for each group). E, STIM1 
movement induced by TG and the effect of HG. Scale bar is 10 µm. F-G, Fluorescent 
intensity of STIM1-EYFP in the plasma membrane and the average STIM1 cluster number in 
the cells (n = 15 cells), *** P<0.001. 
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Supplementary Fig. 1. ORAIs and STIMs in human blood vessels and vascular cells. A, 
The protein bands for ORAI1, ORAI2, ORAI3, STIM1 and STIM2 were detected by Western 
blotting in EA.hy926 cells. B, ORAI1-3 detected in human left internal mammary artery 
(LIMA).  
  
Supplementary Fig. 2. ORAI and STIM expression regulated by high glucose and Ca
2+
-
calcineurin inhibitor in rat aortic smooth muscle cells. A, The mRNA level quantified by 
real-time PCR in rat aortic smooth muscle cells after treatment with high glucose (25 mM), 
the mannitol (19.5 mM) plus 5.5 mM glucose as equal osmolarity control (n = 3 for each 
group). B, The mRNA level in rat aortic smooth muscle cells treated with high glucose (25 
mM), cyclosporin A (CsA, 200 nM), and high glucose plus CsA for 48 h (n = 3 for each 
group). β-actin was used for relative quantification and triplicate reactions were set for each 
sample detection. *P<0.05, **P<0.01, ***P<0.001.  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Fig. 3. ORAI and STIM expression in streptozotocin (STZ)-induced 
diabetic mice A, ORAI and STIM expression in STZ-induced diabetic mice (n = 6), the mice 
injected with vehicle as control group. The mRNA levels of ORAIs and STIMs detected by 
real-time PCR in the aorta samples. Triplicate RT-PCR reactions were performed for each 
sample. *P<0.05; **P<0.01. 
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 Supplementary Table 1. Primer sequences for RT-PCR 
Gene Species Accession No F/R Primer sequence (5’ to 3’) 
Tm 
(C) 
Location 
Size 
(bp) 
-actin Human NM_001101.3 F ACAGAGCCTCGCCTTTGC 65.7 30-47 211 
 Human NM_001101.3 R GGAATCCTTCTGACCCATGC 65.7 240-221  
 Mouse NM_007393.3 F TGTTACCAACTGGGACGACA 60 304-324 165 
 Mouse NM_007393.3 R GGGGTGTTGAAGGTCTCAAA 59.94 468-449  
ORAI1 Human NM_032790 F AGGTGATGAGCCTCAACGAG 70.1 378-397 238 
 Human NM_032790 R CTGATCATGAGCGCAAACAG 69.5 615-596  
 Rat NM_001013982 R CTGATCATGAGGGCGAACAG 65.8 491-510   
ORAI2 Human NM_001126340 F CATAAGGGCATGGATTACCG 66.7 296-315 210 
 Human NM_001126340 R CGGGTACTGGTACTGCGTCT 67.8 505-486  
 Mouse NM_178751.3 F CACAAGGGCATGGATTACCG 67.3 193-212  210 
 Mouse NM_178751.3 R AGGGTACTGGTACTTGGTCT 56.6 402-383  
ORAI3 Human NM_152288.2 F GGCTACCTGGACCTCATGG 58.9 306-324 176 
 Human NM_152288.2 R GGTGGGTACTCGTGGTCACT 58.3 462-481  
 Mouse NM_198424 F GGCTACCTGGACCTTATGG 60.9 274-292 176 
 Mouse NM_198424 R GGTGGGTATTCATGATCGTT 61.1 449-430  
 Rat NM_001014024 F GGCTACCTCGACCTTATGG 61.1 253-271 176 
 Rat NM_001014024 R GGTGGGTATTCATGATCGCT 63.7 409-428   
STIM1 Human NM_003156 F TGTGGAGCTGCCTCAGTATG 58.41 995 -1014 183 
 Human NM_003156 R AAGAGAGGAGGCCCAAAGAG 58.47 1177 - 1158  
 Mouse NM_009287 F TGTGGAGCTGCCACAGTATG 65.1 1024-1042  182 
 Mouse NM_009287 R AAGAGAGGAGGCCCAAACAG 64.5 1205-1186   
STIM2 Human NM_020860 F CAGCCATCTGCACAGAGAAG 58.12 857 - 876 202 
 Human NM_020860 R AGGTTCGTGCACTGCTATCC 58.75 1058 - 1039  
 Mouse NM_001081103 F TAGTCACCTGCACAGAGAAG 58.2 688-707 202 
 Mouse NM_001081103 R AGTTTCATGAACTGCTATCC 55.8 889-870  
 
 
 
  
 
 
Supplementary Table 2. Blood glucose level and body weight in type 1 diabetic mouse 
models  
 n Start Final n Start Final 
  Vehicle  Streptozotocin 
Blood glucose (mM) 6 9.11±0.33  9.21±0.39 6 7.99±0.28 21.48±1.2*** 
Weight start (g)  6 23.91±1.6  31.30±1.00 6 22.20±1.3  26.49±0.62*** 
       
 Wide-type   Akita mice 
Blood glucose (mM) 6 7.99±0.99 8.01±1.27 6 21.90±1.91 21.38±1.92***  
Weight start (g)  6 18.29±0.42 18.86±0.73 6 18.00±0.75  18.71±0.80  
 
Note: Comparison between the control (vehicle or wild-type) and streptozotocin-treated or 
Akita mice group.  *** P<0.001. 
 
 
 
 
 
 
 
